At an extraordinary general meeting on August 21, Pharmiva’s shareholders approved the planned merger between Peptonic Medical AB (“Peptonic”) and Pharmiva AB (“Pharmiva”). The merger
GROUP 2023 SECOND QUARTER (April-June) 2023 FIRST HALF YEAR (April-June) Message from our CEO Important steps towards establishing a leading Swedish Femtech Company We are
Peptonic Medical AB (publ) today announces that Albert Lindgren has been appointed Chief Financial Officer (CFO) and member of Group Management. He will take up
PEPTONIC Medical AB today announced that the company has signed a license agreement with Swiss medical device company Prima Lab SA for the sale of
Peptonic Medical AB (publ) today announces that the Stockholm District Court has rejected the Swedish Economic Crime Authority’s (EBM) claim for a corporate fine for
The FemTech companies PEPTONIC medical AB (“Peptonic”), listed on Spotlight Stock Market, and Pharmiva AB (publ) (“Pharmiva”), listed on Nasdaq First North Growth Market, have
